Literature DB >> 10607869

Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators in vivo.

P Agvald1, L C Adding, L E Gustafsson, M G Persson.   

Abstract

Nitric oxide (NO) increments in exhaled air and changes in mean arterial pressure of anaesthetised rabbits were measured in order to study the NO generation from NO donors and tachyphylaxis in NO formation from nitroglycerin. Continuous infusions of isosorbide dinitrate, isosorbide-5-mononitrate and 3-morpholino-sydnonimine (SIN-1) evoked dose-dependent increases in exhaled NO, paralleled by decrements in mean arterial pressure. Repeated infusions of nitroglycerin resulted in attenuation (P<0.01) of the NO increase from a given dose. Concurrent infusions of isosorbide dinitrate, isosorbide-5-mononitrate or nitroglycerin reduced the amount of NO emanating from the bioconversion of a given dose nitroglycerin as measured in the expired air (P<0.01 for all drugs), indicating cross-tachyphylaxis. SIN-1 did not exhibit such cross-tachyphylaxis. In conclusion, measurements of exhaled NO can be a useful tool for exploration of nitrovasodilator tachyphylaxis. Cross-tachyphylaxis is only shared between some nitrovasodilators and is possibly not due to feedback from the generated NO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607869     DOI: 10.1016/s0014-2999(99)00720-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.

Authors:  Scott P Nichols; Wesley L Storm; Ahyeon Koh; Mark H Schoenfisch
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

2.  Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxia in vivo.

Authors:  Per Agvald; L Christofer Adding; Andreas Artlich; Magnus G Persson; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.

Authors:  Bryan T Oronsky; Susan J Knox; Jan J Scicinski
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

4.  Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

Authors:  Yan Li; Xizhong Cui; Wanying Xu; Lernik Ohanjanian; Hanish Sampath-Kumar; Dante Suffredini; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-22       Impact factor: 4.733

5.  Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery.

Authors:  Gergely Lautner; Mark E Meyerhoff; Steven P Schwendeman
Journal:  J Control Release       Date:  2016-01-05       Impact factor: 9.776

6.  An ultra-rapid development of tachyphylaxis to nitroglycerin.

Authors:  Harihar V Hegde; N Jagadish; P Raghavendra Rao
Journal:  Indian J Anaesth       Date:  2014 Nov-Dec

7.  Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.

Authors:  Kristofer F Nilsson; Lars E Gustafsson
Journal:  Pharmacol Res Perspect       Date:  2019-01-22

8.  A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension.

Authors:  Anna Stene Hurtsén; Ilya Zorikhin Nilsson; Emanuel M Dogan; Kristofer F Nilsson
Journal:  Drug Des Devel Ther       Date:  2020-02-17       Impact factor: 4.162

9.  Blockade of the natriuretic peptide clearance receptor attenuates proteinuria in a mouse model of focal segmental glomerulosclerosis.

Authors:  Liming Wang; Yuping Tang; Anne F Buckley; Robert F Spurney
Journal:  Physiol Rep       Date:  2021-11

10.  Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.

Authors:  Kristofer F Nilsson; Waldemar Goździk; Claes Frostell; Stanisław Zieliński; Marzena Zielińska; Kornel Ratajczak; Piotr Skrzypczak; Sylwia Rodziewicz; Johanna Albert; Lars E Gustafsson
Journal:  Drug Des Devel Ther       Date:  2018-03-29       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.